Learn more

HOUSTON BIOTECHNOLOGY

Overview
  • Total Patents
    50
About

HOUSTON BIOTECHNOLOGY has a total of 50 patent applications. Its first patent ever was published in 1987. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, machines and medical technology are MAELOR PHARMACEUTICALS LTD, AMRYT RES LIMITED and REHEAL CHONGQING BIOTECHNOLOGY CO LTD.

Patent filings per year

Chart showing HOUSTON BIOTECHNOLOGYs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Kelleher Peter J 14
#2 Potter David E 12
#3 Wallace Thomas L 10
#4 Chiou George C Y 9
#5 Crosson Craig E 8
#6 Lam Dominic Man-Kit 7
#7 Tilton Marti Jett 5
#8 Lam Dominic M K 4
#9 Jett-Tilton Marti 4
#10 Varma Rajender Singh 3

Latest patents

Publication Filing date Title
US6063396A Methods and compositions for the modulation of cell proliferation and wound healing
AU2823495A Methods and compositions for modulation of wound healing
WO9503828A1 Single-chain immunotoxin compositions and methods for preventing secondary cataracts
WO9503783A1 Polymeric device for the delivery of immunotoxins for the prevention of secondary cataract
AU4800593A Polymeric device for the delivery of immunotoxins for the prevention of secondary cataract
US5876438A Polymeric device for the delivery of immunotoxins for the prevention of secondary cataract
WO9412634A1 Neurotrophic factor
AU3222993A Neurotrophic factor
WO9006123A1 Therapeutic use of calcium entry blockers in retinal or optic nerve dysfunction
US5166317A Neurotrophic factor
IE883005L Inhibiting proliferation of a virus in host cells
AU2601988A Phosphatidyl treatment of viral disease
US4859674A Pyrazine in prevention and treatment of strokes
US4997761A Phosphatidyl treatment of viral disease
US4865599A Ophthalmic compositions for treating nerve degeneration
FI873428A0 Ophthalmic composition for behandling av nervdegenerationer.